Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

The FTSE 100 (^FTSE) touched all-time highs and European indices gained on Tuesday afternoon as traders priced in a higher ...

NVIDIA (NasdaqGS:NVDA) is expanding its AI reach through new partnerships in industrial virtual twins with Dassault Systèmes.

Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question.

Quantum software startup Classiq Technologies Ltd. said today it has partnered with Comcast Corp. and Advanced Micro Devices Inc. to showcase how quantum computers can dramatically enhance network ...

Comcast recently completed a networking trial with AMD and Classiq that showed the ability to leverage a quantum system to ...

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF treatment ...

BTCC, the world’s longest-serving cryptocurrency exchange, announces the launch of BTCC TradFi, a new cross-market feature that gives users direct access to forex, commodities, indices, and stocks, ...

On Monday, Advanced Micro Devices Inc. AMD said it is expanding work with Tata Consultancy Services to roll out its newest AI ...

Investing.com -- Ocular Therapeutix (NASDAQ:OCUL) stock fell 35% Tuesday despite the company reporting positive results from its Phase 3 superiority trial for AXPAXLI in wet age-related macular ...

Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's approved treatment Eylea in a late-stage trial ...

Chipmaker AMD is deepening its India push through an expanded partnership with India's largest IT services company Tata ...